» Articles » PMID: 29391358

Wave of Renal Impairment

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2018 Feb 3
PMID 29391358
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

We present a case of a 51-year-old man who went to the emergency department after an almost-drowning episode, presenting with muscular weakness, myalgia and dark urine. Laboratory data showed a severe rhabdomyolysis (creatine kinase 497 510 U/L). Despite aggressive fluid therapy, an oliguric acute kidney injury was established with temporary need of haemodialysis. The patient had a longtime history of exercise intolerance and family history of a metabolic myopathy, namely a sister with McArdle's disease. The genetic test was positive. McArdle's disease is an autosomal recessive disorder caused by mutations in the muscle glycogen phosphorylase gene that encodes the myophosphorylase. The main symptom consists in exercise intolerance and the most severe complication is rhabdomyolysis with acute renal failure. Metabolic myopathies, such as McArdle's disease, should be considered in patients with acute renal failure due to unexplained severe rhabdomyolysis, especially if there are chronic complaints of exercise intolerance and positive family history.

Citing Articles

Clinical Presentation and Management of Severe Acute Renal Failure in McArdle Disease.

Hamadeh M, Nasrallah K, Ajami Z, Zeaiter R, Abbas L, Hamadeh S Clin Med Res. 2021; 19(2):90-93.

PMID: 33985978 PMC: 8231694. DOI: 10.3121/cmr.2021.1641.

References
1.
Allison R, Bedsole D . The other medical causes of rhabdomyolysis. Am J Med Sci. 2003; 326(2):79-88. DOI: 10.1097/00000441-200308000-00005. View

2.
Martinuzzi A, Liava A, Trevisi E, Frare M, Tonon C, Malucelli E . Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease. Muscle Nerve. 2007; 37(3):350-7. DOI: 10.1002/mus.20937. View

3.
Petejova N, Martinek A . Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care. 2014; 18(3):224. PMC: 4056317. DOI: 10.1186/cc13897. View

4.
Mate-Munoz J, Moran M, Perez M, Chamorro-Vina C, Gomez-Gallego F, Santiago C . Favorable responses to acute and chronic exercise in McArdle patients. Clin J Sport Med. 2007; 17(4):297-303. DOI: 10.1097/JSM.0b013e3180f6168c. View

5.
Vorgerd M, Grehl T, Jager M, Muller K, Freitag G, Patzold T . Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Arch Neurol. 2000; 57(7):956-63. DOI: 10.1001/archneur.57.7.956. View